Related Experiment Video

Updated: Apr 25, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.7K

A preliminary study on methylphenidate-regulated gene expression in lymphoblastoid cells of ADHD patients

Ricarda Schwarz1, Andreas Reif, Claus-Jürgen Scholz

  • 1Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg , Würzburg , Germany.

The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|August 28, 2014
PubMed
Abstract

Insights

Methylphenidate (MPH) impacts gene expression in attention-deficit/hyperactivity disorder (ADHD) patients. This study identified specific gene expression changes in ADHD patients and controls treated with MPH, suggesting a role in ADHD pathophysiology.

Area of Science:

  • Neuroscience
  • Pharmacogenomics
  • Molecular Biology

Background:

  • Methylphenidate (MPH) is a primary treatment for attention-deficit/hyperactivity disorder (ADHD).
  • Emerging evidence suggests MPH directly influences gene expression beyond its known effects on monoamine reuptake.

Purpose of the Study:

  • To investigate the genome-wide impact of MPH on gene expression in lymphoblastoid cells from adult ADHD patients and healthy controls.
  • To identify specific genes regulated by MPH treatment in ADHD and control populations.

Main Methods:

  • Hypothesis-free, genome-wide microarray analysis of lymphoblastoid cells.
  • Quantitative Real-Time PCR (qRT-PCR) for validation of significant microarray findings.

Main Results:

  • Microarray analysis identified 138 genes marginally regulated by MPH treatment and one gene by diagnosis.
  • qRT-PCR confirmed differential expression of GUCY1B3 by diagnosis.
  • MPH treatment affected expression of ATXN1, HEY1, MAP3K8, and GLUT3 in controls, and NAV2 and ATXN1 in ADHD patients.

Conclusions:

  • Preliminary findings indicate MPH treatment induces differential gene expression in ADHD patients versus healthy controls.
  • Further validation in larger cohorts and neuronal cell models is necessary to confirm gene contributions to ADHD pathophysiology and MPH's mechanism of action.
Keywords:
attention-deficit-/hyperactivity disorderdisease modelsgene expressionmethylphenidatemicroarray analysis

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

10.3K
Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

9.3K

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80